Clinical Trial Update: Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists [NA]

View source ↗

Summary

This clinical trial update concerns using QuantiFERON-TB Gold to assess latent tuberculosis in patients with rheumatoid arthritis or spondyloarthritis who are c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Spondyloarthritis
• Tuberculosis

Drugs mentioned

• QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)

Snippet

Sponsor: ASST Fatebenefratelli Sacco | Conditions: Rheumatoid Arthritis, Spondylarthritis | NA | Status: UNKNOWN